Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Optical Detection of Intravenous Infiltration

This study has been completed.
Information provided by (Responsible Party):
Leonard Winchester, Ph.D., CW Optics, Inc. Identifier:
First received: May 18, 2010
Last updated: February 9, 2012
Last verified: February 2012

The purpose of this study is to investigate the safety and efficacy of an optical device designed and developed for monitoring the intravenous infusion site for infiltration. The hypothesis is that the changes in optical signals measured near the infusion site using the optical device can be used to monitor intravenous infusion for infiltration.

Intravenous Infiltration
Extravasation of Diagnostic and Therapeutic Materials

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Optical Detection of Intravenous Infiltration

Further study details as provided by CW Optics, Inc.:

Primary Outcome Measures:
  • Test performance of novel optical device for monitoring intravenous infusion site for infiltration. [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]

Enrollment: 263
Study Start Date: May 2010

Ages Eligible for Study:   3 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects recruited from the patient population at Virginia Commonwealth University Health System will be enrolled in the Study.


Inclusion Criteria:

  • Subjects will have peripheral IV catheter with active infusions that are anticipated to be in place and functioning for 48-72 hours. The IVs and accompanying infusions are solely a part of the subject's medical care and are not started or terminated for the purposes of this Study. The rationale for choosing this time frame is that the rate of infiltration is likely to be increased the longer the IV infusion is taking place.
  • Subjects are admitted to one of the institution's intensive care or intermediate care units, including Adult Emergency Department, Pediatric Emergency Department, Adult Medical Intensive Care Unit, Pediatric Intensive Care Unit, Neonatal Intensive Care Unity, Surgical-Trauma Intensive Care Unit, Cardiothoracic Surgery Intensive Care Unit, Neuroscience Intensive Care Unit, Burn Intensive Care Unit, Transplant Intensive Care Unit, Coronary Care Intensive Care Unit, Post-Anesthesia Recovery Unit, Pediatric Intermediate Care Unity, Surgical Intermediate Care Unit, and Medical Intermediate Care Unit.

Exclusion Criteria:

  • Inability to consent
  • Lack of a peripheral IV
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01126710

United States, Virginia
Virginia Commonwealth University Health System
Richmond, Virginia, United States, 23298
Sponsors and Collaborators
CW Optics, Inc.
  More Information

No publications provided

Responsible Party: Leonard Winchester, Ph.D., Chief Scientific Officer, CW Optics, Inc., CW Optics, Inc. Identifier: NCT01126710     History of Changes
Other Study ID Numbers: IV-2010-01, 5R44HL062008-06
Study First Received: May 18, 2010
Last Updated: February 9, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by CW Optics, Inc.:
optical monitoring

Additional relevant MeSH terms:
Extravasation of Diagnostic and Therapeutic Materials
Pathologic Processes
Wounds and Injuries processed this record on November 20, 2014